Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

Doctors and nutritionists have told The Independent that those who have lost weight need robust support to make lifestyle ...

India on verge of lung cancer epidemic; Study warns India faces a looming lung cancer crisis—and it's hitting non-smokers ...

When people stop taking the new generation of weight-loss drugs they pile back on the kilos four times faster than they would after ending diet and exercise regimens, new research found Thursday.

Eli Lilly is riding the wave of a booming weight management market. Eli Lilly's tirzepatide, sold under the brand names ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Weight loss drugs like Ozempic and Wegovy have had a meteoric rise in recent years, but how fast does the weight return after ...

Eli Lilly said combining Taltz and Zepbound improved arthritis symptoms and drove meaningful weight loss, outperforming Taltz ...

Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...

Explore the Latest Research Peptides from Biotech Labz Supply Sebastopol, United States – January 4, 2026 / Biotech Labz ...